multigam 5 % inf. opl. i.v. flac.
centrale afdeling voor fractionering - departement central de fractionnement s.p.r.l.-b.v.b.a. - humane normale immunoglobulinen 50 mg/ml - oplossing voor infusie - 5% - humane polyvalente immunoglobulinen 50 mg/ml - immunoglobulins, normal human, for intravascular adm.
multigam 5 % inf. opl. i.v. flac.
centrale afdeling voor fractionering - departement central de fractionnement s.p.r.l.-b.v.b.a. - humane normale immunoglobulinen 50 mg/ml - oplossing voor infusie - 5% - humane polyvalente immunoglobulinen 50 mg/ml - immunoglobulins, normal human, for intravascular adm.
multigam 5 % inf. opl. i.v. flac.
centrale afdeling voor fractionering - departement central de fractionnement s.p.r.l.-b.v.b.a. - humane normale immunoglobulinen 50 mg/ml - oplossing voor infusie - 5% - humane polyvalente immunoglobulinen 50 mg/ml - immunoglobulins, normal human, for intravascular adm.
multigam 10 % inf. opl. i.v. flac.
centrale afdeling voor fractionering - departement central de fractionnement s.p.r.l.-b.v.b.a. - humane normale immunoglobulinen 100 mg/ml - oplossing voor infusie - 10 % - humane normale immunoglobulinen 100 mg/ml - immunoglobulins, normal human, for intravascular adm.
multigam 10 % inf. opl. i.v. flac.
centrale afdeling voor fractionering - departement central de fractionnement s.p.r.l.-b.v.b.a. - humane normale immunoglobulinen 100 mg/ml - oplossing voor infusie - 10 % - humane normale immunoglobulinen 100 mg/ml - immunoglobulins, normal human, for intravascular adm.
multigam 10 % inf. opl. i.v. flac.
centrale afdeling voor fractionering - departement central de fractionnement s.p.r.l.-b.v.b.a. - humane normale immunoglobulinen 100 mg/ml - oplossing voor infusie - 10 % - humane normale immunoglobulinen 100 mg/ml - immunoglobulins, normal human, for intravascular adm.
multigam 10 % inf. opl. i.v. flac.
centrale afdeling voor fractionering - departement central de fractionnement s.p.r.l.-b.v.b.a. - humane normale immunoglobulinen 100 mg/ml - oplossing voor infusie - 10 % - humane normale immunoglobulinen 100 mg/ml - immunoglobulins, normal human, for intravascular adm.
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - ophthalmologica - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologica - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologica - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).